CUPERTINO, Calif., Aug. 9 /PRNewswire-FirstCall/ — DURECT Corporation
(Nasdaq: DRRX) announced today that it will present at the Halpern Capital
Summer Growth Stock Conference. The conference is being held at The Campton
Place Hotel in San Francisco, CA. Dr. Felix Theeuwes, Chairman and Chief
Scientific Officer, will be presenting at the conference on Tuesday,
August 10, 2004 at 8:20 a.m. Pacific Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )
A live audio webcast of the presentation will be available by accessing
DURECT’s homepage at http://www.www.durect.com and clicking “Investor Relations”.
DURECT Corporation (www.www.durect.com) is pioneering the development and
commercialization of pharmaceutical systems for the treatment of chronic
debilitating diseases and enabling biotechnology-based pharmaceutical
products. DURECT’s goal is to deliver the right drug to the right site in the
right amount at the right time.
SOURCE DURECT Corporation
/CONTACT: Schond L. Greenway, Executive Director, Investor Relations and
Strategic Planning of DURECT Corporation, +1-408-777-1417/
/Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, +1-888-776-6555 or +1-212-782-2840/
/Web site: http://www.www.durect.com/